Migraine
Not recruitingStudy on Lu AG09222 for Preventing Migraines in Adults Unresponsive to Previous Treatments
- Disease:Migraine
- Substances:Lu Ag09222
Slovakia- Participants:18–64 years
- Substances:Lu Ag09222
- Sponsor:H. Lundbeck A/S
Rare diseases
Investigational molecules
Locations
Back to Slovakia7 clinical trials in Nova Dubnica, Slovakia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SlovakiaKlinickeSkusky.sk(opens in a new tab)
Slovakia
Slovakia
Slovakia
Slovakia
Slovakia
Slovakia
SlovakiaThe busiest research cities in the country
What the registry says about research in the country
Clinical research focusing on Alzheimer's Disease treatments, including studies evaluating new therapies for early-stage patients with inflammatory biomarkers and investigating treatments for agitation in dementia patients.
These trials aim to improve cognitive performance and quality of life for patients with neurodegenerative conditions.
Comprehensive research into various forms of epilepsy, with particular focus on developing treatments for primary generalized tonic-clonic seizures and absence epilepsy in younger patients.
Clinical investigations are evaluating both short-term efficacy and long-term safety of anticonvulsant therapies.
Innovative research exploring preventative treatments for migraine patients who have not responded to conventional therapies, testing new approaches to chronic pain management.
These studies focus on developing alternative solutions for patients with difficult-to-treat neurological pain conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.